Jianfeng Group 2015 Annual Profit Distribution Implementation Announcement
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2016-025
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
2015 Profit Distribution Implementation Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important Note:
● Profit Distribution Ratio: Cash Dividend 1.8 Yuan (Including Tax) for Every 10 Shares
● Cash Dividend Per Share Before and After Tax Deduction: Cash Dividend Per Share 0.18 Yuan Before Tax Deduction Yuan; Non-restricted natural person shareholders and securities investment funds will not withhold personal income tax for the time being, when the shares held are actually transferred, the tax payable shall be calculated according to the shareholding period; qualified foreign institutional investors ("QFII") shareholders and Hong Kong market investors (including enterprises and individuals) will pay a cash dividend of 0.162 yuan per share; for other institutional investors And corporate shareholders, the actual cash dividend per share is 0.18 yuan.
● Equity Registration Date: June 45 29, 2016
● Ex-rights (ex-dividend) Date: June 51 30, 2016
● Cash Dividend Payment Date: 2016June 30
1.The session and time of the shareholders' meeting that passed the distribution plan
Zhejiang Jianfeng Group Co., Ltd. 2015annual profit distribution plan was reviewed and approved by the company's 2015 annual shareholders' meeting held on May 9, 2016. The announcement of the resolution of the general meeting of shareholders was published in China Securities Journal, Shanghai Securities News and the website of Shanghai Stock Exchange (http://www.sse.com.cn ) on May 10, 2016.
2.Distribution Plan
(I)Issuance Year: 2015 Year
(II)Issuance Scope:
2016After closing at the Shanghai Stock Exchange on the afternoon of June 29, 86, in Shanghai Branch of China Securities Depository and Clearing Corporation Limited (hereinafter referred to: "Zhongdeng Shanghai Branch") is a registered shareholder of the Company.
This distribution is based on 344,083,828 shares of 2015at the end of the year, and a cash dividend of 1.8 yuan (including tax) will be distributed to all shareholders for every 10 shares, totaling 61,935,089.04 yuan.
(III)Tax Deduction Note
1, Cash Dividends for Natural Person Shareholders and Securities Investment Funds Holding Unlimited Circulating Shares of the Company, in accordance with the relevant provisions of the Notice on Issues Relating to Differentiated Individual Income Tax Policies on Dividends and Bonuses of Listed Companies (Caishui [2015] No. 101) and the Notice on Issues Relating to the Implementation of Differentiated Individual Income Tax Policies on Dividends and Bonuses of Listed Companies (Caishui [2012] No. 85), if the holding period (the holding period refers to the duration from the date when an individual acquires the company's shares in the public offering and transfer market to the day before the transfer and delivery of the shares) is less than one month (including one month), the full amount of dividend income shall be included in the taxable income, and the actual tax burden shall be 20%; if the holding period is more than one month to one year (including one year), its dividend income is included in the taxable income at 50%, and the actual tax burden is 10%; if the holding period exceeds 1 year, the dividend income is temporarily exempt from personal income tax. The company does not withhold personal income tax for the time being. When it transfers its shares, Zhongdeng Shanghai Branch will calculate the tax payable according to its shareholding period, and the securities company and other share custodian institutions will deduct and pay Zhongdeng Shanghai Branch from its capital account. Zhongdeng Shanghai Branch will pay the company within 5 working days of the following month, and the company will report and pay the tax to the competent tax authority within the statutory reporting period of the month in which the month.
2, For the cash dividends of qualified foreign institutional investors (QFII ) holding the company's stocks, according to the "Regarding the payment of dividends, dividends, and interest to QFII by Chinese resident enterprises The relevant provisions of the Notice on Issues Concerning the Withholding of Enterprise Income Tax (Guoshuihan [2009] No. 47) (hereinafter referred to as the" Notice "), the company withholds and pays corporate income tax at a tax rate of 10%, and the actual cash dividend per share after tax deduction is 0.162 yuan. If the relevant shareholder considers that the dividend income received by him is subject to any tax treaty (arrangement) treatment, the shareholder may, in accordance with the provisions of the Notice, apply to the competent tax authorities on his own initiative after the dividend has been received.
3. For investors (including enterprises and individuals) investing in the company A shares ("Shanghai Stock Connect") on the Hong Kong Stock Exchange, the cash dividend will be distributed by the company through Zhongdeng Shanghai Branch in RMB according to the account of the nominal holder of the shares, tax deduction is implemented in accordance with the "Notice of the Ministry of Finance, the State Administration of Taxation, and the China Securities Regulatory Commission on the Relevant Tax Policies for the Pilot Interconnection Mechanism of Shanghai and Hong Kong Stock Market Transactions" (Caishui [2014] No. 81), and the income tax is withheld at a tax rate of 10%. Cash dividends of RMB 0.162 per share were actually distributed.
4. For company shareholders (including institutional investors) who belong to the meaning of resident enterprises under the Enterprise Income Tax Law, their income tax shall be paid by themselves, and the actual cash dividend shall be 0.18 yuan per share.
3.Distribution Plan Implementation Date
(I)Equity Registration Date: 2016 June 29
(II)Ex-rights (Ex-dividend) Date: 2016 June 30
(III)Cash Dividend Payment Date: 2016# June 141 142
4.
Distribution ObjectAll shareholders of the Company registered in Shanghai Branch of China Securities Depository and Clearing Corporation Limited after the closing of the Shanghai Stock Exchange on the afternoon of June 29, 152 (date of record).
5.
Dividends Implementation Measures
(I) The cash dividends of Jinhua Tongji State-owned Assets Investment Co., Ltd., a shareholder of the Company, are directly distributed by the Company.
(II) the cash dividends of other shareholders of the company other than Jinhua Tongji State-owned Assets Investment Co., Ltd., the company entrusts Zhongdeng Shanghai Branch to register and register with the Shanghai Stock Exchange through its capital clearing system. Distribute to shareholders who have handled designated transactions. Investors who have completed a fully designated transaction may receive cash dividends at their designated securities business department on the dividend payment date, while shareholders' dividends that have not completed the designated transaction are temporarily kept by Zhongdeng Shanghai Branch and will be distributed after the designated transaction is completed.
6. Relevant Consultation Measures
Address: Office of the Board of Directors of Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang Province
Tel: 0579-82324699 ; Fax: 0579-177
7. Reference Document Catalogue
Resolution of the Company's 2015 Annual General Meeting.
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors2016# June 24, 197, 196
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31